Last reviewed · How we verify
Dermatofibrosarcoma protuberans
Approved treatments
- Gleevec · M.D. Anderson Cancer Center
- Gleevec · Novartis
Gleevec works by blocking the activity of specific enzymes involved in cancer cell growth and proliferation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Dermatofibrosarcoma protuberans patent landscape — cliff calendar, originator estates, attackable patents
- Dermatofibrosarcoma protuberans treatment landscape brief
- Dermatofibrosarcoma protuberans treatment updates RSS
Frequently asked questions about Dermatofibrosarcoma protuberans
What drugs treat Dermatofibrosarcoma protuberans?
Tracked treatments include Gleevec.
What is the treatment for Dermatofibrosarcoma protuberans?
Standard treatment for Dermatofibrosarcoma protuberans includes Gleevec. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Dermatofibrosarcoma protuberans patent cliff · Dermatofibrosarcoma protuberans CI report
- Treatment: Gleevec · M.D. Anderson Cancer Center
- Treatment: Gleevec · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing